CALR and myeloproliferative neoplasm: The NAP rate of the MPN patients with CALR mutations was lower (n = 13; median NAP rate 55 %; range 38–91 %), mainly due to the high proportion of NAP-negative neutrophils (score = 0; Fig. 2).